ethosuximide has been researched along with losartan potassium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Böcker-Meffert, S; Held-Feindt, J; Lucius, R; Röhl, C; Rosenstiel, P; Sievers, J; Warneke, N | 1 |
2 other study(ies) available for ethosuximide and losartan potassium
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats.
Topics: Animals; Animals, Newborn; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Growth Factors; Erythropoietin; Ethosuximide; Female; Immunohistochemistry; Lymphokines; Male; Nerve Regeneration; Neurites; Proto-Oncogene Proteins; Rats; Rats, Inbred F344; Receptor Protein-Tyrosine Kinases; Receptors, Erythropoietin; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Retinal Ganglion Cells; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2002 |